Getagraph.com logo
NASDAQ Composite: ( -1.08%) 16 737
S&P 500 Futures
(-0.21%) 5 241.75 points
Dow Jones Futures
(-0.08%) 38 202 points
Nasdaq Futures
(-0.35%) 18 541 points
Oil
(-0.31%) $77.67
Gas
(-0.86%) $2.55
Gold
(-0.13%) $2 363.50
Silver
(-0.49%) $31.38
Platinum
(-0.42%) $1 033.60
USD/EUR
(-0.07%) $0.922
USD/NOK
(-0.18%) $10.52
USD/GBP
(0.07%) $0.786
USD/RUB
(0.03%) $90.29

Realtime updates for Addex Therapeutics Ltd [ADXN.SW]

Exchange: SIX Industry: Pharmaceuticals, Biotechnology & Life Sciences
Last Updated31 May 2024 @ 03:05
25% discount on Stockinvest.us - Use code: Podcast

-2.64% CHF 0.0664

Live Chart Being Loaded With Signals

Commentary (31 May 2024 @ 03:05):

Addex Therapeutics Ltd, a development-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule pharmaceutical products for central nervous system (CNS) disorders in Switzerland...

Stats
Today's Volume 9 040.00
Average Volume 1.23M
Market Cap 11.85M
EPS CHF0 ( 2024-05-13 )
Last Dividend CHF0 ( N/A )
Next Dividend CHF0 ( N/A )
P/E -0.470
ATR14 CHF0.00200 (3.01%)

Addex Therapeutics Ltd Correlation

10 Most Positive Correlations
10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Addex Therapeutics Ltd Financials

Annual 2023
Revenue: CHF1.62M
Gross Profit: CHF-5.32M (-328.86 %)
EPS: CHF-0.140
FY 2023
Revenue: CHF1.62M
Gross Profit: CHF-5.32M (-328.86 %)
EPS: CHF-0.140
FY 2022
Revenue: CHF1.42M
Gross Profit: CHF-13.20M (-928.06 %)
EPS: CHF-0.470
FY 2021
Revenue: CHF2.92M
Gross Profit: CHF0.00 (0.00 %)
EPS: CHF-0.450

Financial Reports:

No articles found.

Addex Therapeutics Ltd Options Data

Calls

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Puts

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Addex Therapeutics Ltd

Addex Therapeutics Ltd, a development-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule pharmaceutical products for central nervous system (CNS) disorders in Switzerland. The company focuses on the discovery of oral small molecule allosteric modulators of G-protein coupled receptors. Its lead programs include Dipraglurant for the treatment of Parkinson's disease levodopa-induced dyskinesia, and dystonia; ADX71149 for epilepsy and undisclosed CNS disorders; and GABAB PAM for addiction. It has license and collaboration agreement with Janssen Pharmaceuticals Inc.; Indivior PLC; and The Charcot–Marie–Tooth Association. The company was formerly known as Addex Pharmaceuticals Ltd and changed its name to Addex Therapeutics Ltd in March 2012. Addex Therapeutics Ltd was founded in 2002 and is headquartered in Geneva, Switzerland.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators